Longboard Pharmaceuticals, Inc.
LBPHDelisted Dec 2, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001832168
Longboard Pharmaceuticals, Inc. was delisted on Dec 2, 2024; its insiders filed their last Form 4 on Dec 2, 2024; 125 institutions reported holding it in 13F filings for Q3 2024, worth $1.33B in total; Viking Global Investors was the only superinvestor holding it.
Q4 2024 vs. Q3 2024
How the institutions holding Longboard Pharmaceuticals, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 125 | 1 | 0 | −124 |
| Shares | 39.8M | 12.2K | 0 | −39.8M (−100.0%) |
| Value | $1.33B | $406.6K | $0 | −$1.33B (−100.0%) |
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (0)
Institutions that held Longboard Pharmaceuticals, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
None.
Sold out (124)
Institutions that held Longboard Pharmaceuticals, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
Showing the largest 100 of 124 by value.
Not filed for Q4 2024 yet (1)
Institutions that held Longboard Pharmaceuticals, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Raymond James & Associates | 12,200 | $406.6K |